Molecular subgroup of primary prostate cancer presenting with metastatic biology.
<h4>Background</h4> <p>Approximately 4–25% of patients with early prostate cancer develop disease recurrence following radical prostatectomy.</p> <h4>Objective</h4> <p>To identify a molecular subgroup of prostate cancers with metastatic potential at present...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2017
|